Skip to content

Changes of TMEM74 in peripheral blood of patients with anxiety disorders

Changes of TMEM74 in peripheral blood of patients with anxiety disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018006
Enrollment
Unknown
Registered
2018-08-27
Start date
2018-08-28
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety disorders

Interventions

anxiety disorders versus control group:none

Sponsors

Second Hospital Affiliated to Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) age over 18 years old; 2) past or present DSM-5 diagnostic criteria for generalized anxiety or panic disorder; 3) in acute phase, the Hamilton Anxiety Scale (HAMA) score was 14 points, and the HAMA score in remission stage was 7 points; 4) cultural, social and educational background is sufficient to understand informed consent and research content; 5) enough audio-visual level to complete the necessary examination; 6) with good insight, able to understand diseases and take the initiative to receive treatment.

Exclusion criteria

Exclusion criteria: 1) organic mental disorders, disorder due to psychoactive substances and non addictive substances, and other mental disorders; 2) patients with severe somatic disease.

Design outcomes

Primary

MeasureTime frame
TMEM74;

Countries

China

Contacts

Public ContactChen Qiaozhen

Second Hospital Affiliated to Zhejiang University

simplify@126.com+86 13777867409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026